EOAR SEMINAR, SEPTEMBER 2023
DR. GOOGLE AND CHATGPT: INFORMATION ON EMERGING GENE AND CELL THERAPIES IN THE ERA OF GENERATIVE AI
Dr Anna Couturier (Centre for Regenerative Medicine, University of Edinburgh)
In the age of Generative AI, like ChatGPT, and the ubiquity of search engines, such as "Dr. Google," access to health information has transformed. This presentation explores the impact of these algorithmically-mediated tools on the dissemination of information about emerging gene and cell therapies. With the number of gene and cell therapies moving from the lab towards patients increasing, understanding how digital information technologies influence public perception and decision-making is crucial. We will delve into the challenges of information accuracy, ethical concerns in personalized data usage, and the blurred lines between commercial and non-commercial discourse. This presentation not only highlights the need for transparent governance, but also emphasizes the responsibility of technology companies and the research community in providing reliable, unbiased health information. It underscores the synergy between technology, ethics, and healthcare in an evolving digital landscape.
When: Tuesday, 26th September 2023, 5:30-6:30 PM (ACST)
Where: Online. Please RSVP to email@example.com
Dr Anna Couturier is the Project Manager - Digital and Technical for EuroStemCell and EuroGCT at the University of Edinburgh's Centre for Regenerative Medicine. She steers digital strategy and implementation for the projects in collaboration with their partners and public stakeholders. She also provides in-depth training for scientists and science communicators with a special focus on science and technology in digital spaces. Anna's academic research in Science and Technology Studies at the University of Edinburgh covers algorithmic governance, digital health, and regenerative medicine with a particular interest in developing digitally native methodologies.